Drug evaluation has always been an important area of research in the pharmaceutical
industry. However, animal welfare protection and other shortcomings of traditional drug …

The low probability of a drug candidate's clinical success, the time consumed and the high
cost of bringing a drug from concept to market emphasizes the need for new approaches to …

Existing affinity-based fluorescence biosensing systems for monitoring of biomarkers often
utilize a fixed solid substrate immobilized with capture probes limiting their use in continuous …

Biosensors have attracted a considerable attention in recent years due to their enormous
potential to provide insights into the physical condition of individuals. However, the …

Cardiovascular diseases (CVDs) are a major cause of death worldwide, leading to
increased medical care costs. To turn the scale, it is essential to acquire a more in-depth and …

Cardiovascular diseases are one of the leading global causes of morbidity and mortality,
posing considerable health and economic burden on patients and medical systems …

Microphysiological systems (MPS), also known as miniaturized physiological environments,
have been engineered to create and study functional tissue units capable of replicating …

Microphysiological systems (MPS) are drawing increasing interest from academia and from
biomedical industry due to their improved capability to capture human physiology. MPS offer …

There has been increasing interest and rapid developments in precision medicine, which is
a new medical concept and model based on individualized medicine with the joint …

Recent advances in microphysiological systems (MPS), also known as organs‐on‐a‐chip
(OoC), enable the recapitulation of more complex organ and tissue functions on a smaller …